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Abstract
Purpose Different suture techniques and various suture
materials are in use to close midline incisions after primary
laparotomy. The ISSAAC study aimed to assess the safety
and efficacy of the new ultra-long-term absorbable, elastic
monofilament suture material MonoMax® for abdominal
wall closure.
Methods This is a single-arm, multicentre prospective study
that included 150 patients undergoing a primary elective
midline incision. The control group consists of 141 patients
from the INSECTstudy who received MonoPlus® or PDS®
for abdominal wall closure. The incidences of burst abdo-
men and wound infection until the day of discharge were
defined as the primary composite endpoints. The rate of
incisional hernias 1 year after surgery, the length of postop-
erative hospital stay and safety parameters served as sec-
ondary endpoints. The study has been registered under
www.clinicaltrials.gov [NCT005725079].
Results Eleven patients in the ISSAAC study [7.3%; 95% CI0
(3.9; 13.1%)] experienced wound infection or burst abdomen
until the day of discharge as compared to 16 [11.3%; 95% CI0
(6.6; 17.8%)] patients in the INSECT control group (p00.31).
The length of postoperative hospital stay was comparable in
both study groups. One year after surgery, incisional hernias
were observed in 21 ISSAAC patients (14.0%) in contrast to
30 hernias (21.3%) in the INSECT control group.
Conclusions The ultra-long-term absorbable, elastic mono-
filament suture material MonoMax® is safe and efficient for
abdominal wall closure.
Keywords Laparotomy.Abdominal hernia.Fascia.Suture
materials.Humans
Introduction
Complications related to midline laparotomy are frequent
and sometimes serious. The rate of incisional hernias 1 year
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DOI 10.1007/s00423-011-0884-6postoperatively is estimated to be 9–20% [1–4], the frequen-
cy of reoperation due to burst abdomen 1–3% [5–8] and the
rate of wound infections 3–19% [9–12]. The optimal tech-
nique and suture material for abdominal wall closure have,
therefore, long been a matter of debate [13–19]. A recent
meta-analysis (‘INLINE’)[ 20] that includes data from the
recent INSECT study [1] found a significantly lower hernia
rate following elective abdominal wall closure using a run-
ning suture technique rather than an interrupted suture.
Furthermore, slowly absorbable suture materials produced
significantly fewer hernias than rapidly absorbable sutures
[20]. In contrast to previous meta-analyses [13, 15, 16], the
INLINE meta-analysis found absorbable suture materials to
be superior to non-absorbable sutures regarding the rate of
incisional hernias in the elective situation with slowly ab-
sorbable sutures producing significantly less hernias than
rapidly absorbable sutures [20].
Several synthetic absorbable suture materials with different
tensile strengths and absorption rates have been developed in
thep ast.Th esesu turematerialsareabsorbedbythebodywithin
70 to 180 days, but they also lose 50% of their tensile strength
during the first 14 to 30 days [21]. However, it has been
shown that the abdominal fascia regains only 70% of its
original strength within 1 year after a primary midline
laparotomy [8]. The absorption rate of currently used suture
materials might, therefore, be too fast and prolonged suture
support would be needed for adequate abdominal wall clo-
sure [8]. In conclusion, an ultra-long-term monofilament
absorbable suture material may help to reduce incisional
hernia. First, because of its smooth, monofilament structure
this suture material might reduce wound infections in com-
parison to rough multifilament sutures which promote bac-
terial adherence and migration by their capillary action [22].
Second, due to its high elasticity and flexibility it might
support the mechanics of the abdominal wall and, therefore,
might reduce the risk of tear of the suture from the tissue [23].
Finally, as a result of its ultra-long absorption profile and its
high tensile strength, it would give the fascia more time to
heal and to regain a higher strength which might reduce the
development of incisional hernias compared to conventional
long-term and short-term absorbable sutures [23].
MonoMax® is an ultra-long-term absorbable monofila-
ment suture material with high elasticity and flexibility. It
consists of poly-4-hydroxybutyrate and possesses an
initial strength and a constant degradation rate. The
suture is characterised by high knot tensile strength
retention and long-lasting linear tensile strength reten-
tion, indicating that MonoMax® might be suitable for
abdominal wall closure (Table 1). The ISSAAC study
was, therefore, designed as a historically controlled,
single-arm, multicentre, prospective study to evaluate the
s a f e t ya n de f f i c a c yo fB .B r a u nA e s c u l a pM o n o M a x ®
suture material for abdominal wall closure after primary
median laparotomy.
Methods
The study protocol has been published previously to ensure
the transparency of this study [24]. The final study protocol
was approved by the ethics committee of the University of
Heidelberg. Secondary approval was obtained from all local
ethics committees responsible for the participating centres.
The ISSAAC study was initiated and sponsored by Aescu-
lap AG and conducted in cooperation with the Coordination
Centre for Clinical Trials (KKS) Heidelberg. KKS was
responsible for monitoring, database maintenance and bio-
statistics. Aesculap AG has registered the study under www.
clinicaltrial.gov. During a first investigator meeting, all par-
ticipating centres were trained in the required suture tech-
nique using abdominal wall model mini-pigs as mentioned
in the study protocol [24].
Study design
ISSAAC was designed as a historically controlled, single-
arm, multicentre prospective study to evaluate the safety of
the MonoMax® suture material for abdominal wall closure
following primary midline laparotomy. Patients treated with
PDS® or MonoPlus® suture materials in the preceding
INSECT study [1] served as historical controls. Both study
cohorts were treated in the same centres, and the same
documentation standards and case report forms, where ap-
plicable, were used.
Table 1 Suture material
properties
aP(4-HB) poly-4-
Hydroxybutyrate
bPDO polydioxanone
cBSR basic strength retention
MonoMax
® PDS
® MonoPlus
®
Material P(4-HB)
a PDO
b PDO
b
Linear pull tensile strength 118 N 109 N 113 N
Knot pull tensile strength 74.4 N 63.5 N 60.9 N
Elongation 90% 45–50% 45–50%
Degradation: 50% BSR
c 100 days 42 days 35 days
Mass absorption 390 days 180–210 days 180–210 days
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The inclusion and exclusion criteria as well as the surgical
procedures have been described in the study protocol [24].
The study included patients undergoing primary elective
midline laparotomy with an expected length of skin incision
of at least 15 cm. [Patients with prior laparoscopy or ab-
dominal operation via a paramedian incision (e.g. appen-
dectomy) were also included in the study.] Patients had to be
at least 18 years of age; their BMI had to be inferior to
35 kg/m
2 and their expected survival after surgery more than
12 months.
Exclusion criteria were peritonitis, emergency surgery,
known coagulopathy, severe psychiatric or neurologic dis-
ease, participation in another intervention with a presumed
interference of the intervention or outcome of this study,
drug or alcohol abuse, current immunosuppressive therapy
(more than 40 mg of a corticoid per day or azathioprine),
chemotherapy within 2 months before the operation, radio-
therapy of the abdomen completed less than 8 weeks before
the operation and lack of informed consent. The study,
furthermore, excluded patients not able to understand and
to follow the instructions given by the investigator, pregnant
or breast-feeding women and patients who had been com-
mitted to an institution.
The study was conducted at four centres in Germany:
Heidelberg, Munich, Lingen and Marburg. These centres
were selected as the four most successfully recruiting
centres of the INSECT study. To ensure optimal compara-
bility, in the control group, only INSECT patients from
these four centres were included into analysis. Data from
INSECT patients reported here may therefore differ from the
original study publication that included patients from all
INSECT study centres [1].
Interventions
The surgical procedure for closing the midline incision was
standardised and the same as used in the INSECT study [1,
18]. Starting either from the cranial end or from the caudal
end of the wound, the abdominal wall was closed by placing
four Mikulicz or equivalent clamps at the edges of the
abdominal fascia and a continuous all-layer suture using
two MonoMax® loops (USP1/Aesculap AG, Tuttlingen,
Germany). Before use, in order to avoid breakage of the
material, the monofilament suture MonoMax® was
stretched once by the assisting nurse/operation technician.
The first stitch was anchored cranially and caudally of the
incision. The distance to the edge of the fascia and the
distance between two stitches did not exceed 2 cm to
2.5 cm. After having closed half of the wound, the surgeon
cut one end of the loop immediately below the needle,
passed it from the opposite edge of the fascia and tied both
ends with at least four knots. He proceeded in the same
manner with the loop from the other end of the wound
which intersects the first loop at the middle of the incision,
both sutures lines overlapping at least 2 cm. For every
patient, two loops were used, irrespective of the length of
the wound. No subcutaneous drainage was inserted. The
skin was closed using clips or interrupted monofilament
non-absorbable sutures.
The control group included INSECT patients from the
same four centres that had participated in the ISSAAC
study, whose midline incision was closed with either
PDS® (180 cm loop, USP 1, HRT 48 needle; Ethicon
GmbH, Norderstedt, Germany) or MonoPlus® (150 cm
loop, USP 1, HRT 48 needle; Aesculap AG). The character-
istics of the different suture materials are shown in Table 1.
Outcomes
The frequency of reoperation due to burst abdomen or
wound infection until the day of discharge was chosen as a
primary combined endpoint for safety.
The secondary endpoints, to study efficacy, were the
frequency of abdominal hernias at 12±1 months after sur-
gery, the frequency of wound infections and complicated
wound healing at 30 days after surgery, and the length of
hospital stay.
A hernia was diagnosed if the ultrasound showed a
fascial gap or a protruding sac confirmed by physical exam-
ination. The assessment and documentation were conducted
by a physician who was familiar with the examination of the
abdominal wall but who was not involved in the surgical
procedure. The ultrasound exam had to be carried out by an
investigator who had at least 6 months training in this
method.
Wound infection was defined as redness, wound dehis-
cence with secretion (putrid or caliginous fluid) and/or mi-
crobiological evidence of bacterial contamination. A burst
abdomen was diagnosed if postoperatively the continuity of
the abdominal fascia was interrupted in combination with
wound dehiscence and a consecutive relapse operation. A
complicated wound healing was recorded if the incision did
not close completely, necrosis of the wound edge or primary
or secondary dehiscence occurred or if the formation of a
seroma, fistula or bleeding was seen.
Study objectives
The primary hypothesis of the study was that the combined
frequency of wound infection and of re-operation due to
burst abdomen until day of discharge was equal or lower in
the ISSAAC study group than in patients enrolled in the
INSECT control group.
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surgery and the length of postoperative hospital stay were
evaluated as secondary endpoints. In addition, the wound
infection rate and complicated wound healing were assessed
30 days postoperatively and were compared to the INSECT
control group.
Sample size
The aim of the study was to reject the null hypothesis that the
rate of events such as wound infections and burst abdomen is
at least 25% at the 5% level. If the true rate of composite
endpoints is 15%, it was aimed to have a power of 90% for
this test. With 140 patients, the power was estimated to be
90%. It had been expected that the historical control group
would comprise about 130 patients who had been enrolled
into the INSECT study. To make the comparison with the
historical control group as meaningful as possible, the size
of the MonoMax® group should not exceed the size of the
control group by too much and had been accordingly estab-
lished at 150 patients, including expected 10 dropouts.
Statistical methods
Patients were analysed using the intention to treat (ITT) prin-
ciple. A patient belonged to the ITT population after con-
firmed completion of the surgical intervention by an
enrolment fax form. One patient was excluded from the ret-
rospectiveINSECTcohortbecausenopostoperativedatawere
recorded for him.
The primary endpoint was a composite event com-
prising wound infection and burst abdomen until day
of discharge after surgical intervention. The event rate
was assessed by calculating the exact 95% and 90%
confidence intervals based on Clopper and Pearson
method [25]. Additionally and as a secondary analysis, a
confidence interval for the odds ratio of wound infections
and burst abdomen was calculated using likelihood ratio
methods in a logistic regression model. The event rates of
wound infection and reoperation due to burst abdomen until
the day of discharge was compared between the two study
groups with Fisher’s exact test at the 5% level.
The frequency of wound infections and complicated
wound healing 30 days after surgery, the incidence of ab-
dominal hernias after 12±1 months and length of postoper-
ative hospital stay were used as secondary endpoints. The
incidence of abdominal hernias up to 1 year were estimated
by Kaplan–Meier methods and 95% and 90% confidence
intervals were given based on Greenwood’s formula for the
standard error and using the normal approximation of the
distribution of the estimate for the hazard rate. The length of
postoperative hospital stay was compared between study
cohorts using a Cox regression model. These endpoints
were analysed within the ISSAAC study population as well
as in comparison to the historical INSECT control group.
With respect to the other endpoints, Fisher’s exact test
was used for comparison between treatment cohorts.
The analysis was performed after closing the ISSAAC da-
tabase by using the SAS System (SAS Inc., Cary, NC, USA)
accordingtoapreviouslyspecifiedstatisticalanalysisplan[24].
Results
Recruitment
Four study centres included 150 patients between December 5,
2007 and June 30,2008 in the ISSAAC study (Fig.1, Table 2).
One-year follow-up was completed in July 2009. The historical
INSECT control group had been recruited between July 11,
2004 and September 26, 2006, and consisted of 142 patients
allocated either to MonoPlus® or to PDS® suture materials for
abdominal wall closure (Table 2). INSECT patients con-
cluded their 1-year follow-up until October 2007.
Demography and baseline characteristics
Demography and baseline characteristics are shown in Table 3.
There was no significant difference between the two study
groups regarding gender, age, BMI, smoking status and the
percentage of patients with rectus diastasis or umbilical
Fig. 1 Flow chart of patient inclusion and follow-up. Of 150 patients
who signed the informed consent form, 112 were available for follow-
up 1 year after the operation
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than median laparotomy) were seen in the INSECT cohort
(p00.025). This was in line with the higher number of
patients in the INSECT study with previous surgical history
(data not shown).
Colorectal surgery was more often performed in the
historical control group than in the ISSAAC group. More
surgical interventions regarding the pancreas, stomach and
the oesophagus were conducted in the ISSAAC study com-
pared to the control group (Table 3).
The patients’ median length of abdominal wound was
24.1±4.6 cm for the ISSAAC and 23.5±5.3 cm for the
INSECT control group (Table 3).
Surgeons’ experience
All except one surgical intervention in the ISSAAC study
were performed by a board certified surgeon while in the
INSECT study all but 10 surgeries were conducted by a
board certified surgeon. In Munich, one surgeon accom-
plished more than half of the 50 interventions, while in
Lingen all abdominal wall closures were executed by the
same surgeon. In Heidelberg, no surgeon carried out more
than eight surgical procedures.
Primary endpoint
The combined primary endpoint was reoperation due to
burst abdomen and/or wound infection until day of dis-
charge. Eleven patients in the ISSAAC study group [7.3%;
95% CI0(3.9; 13.1%)] had a wound infection and/or a burst
abdomen up to day of discharge. In the INSECT control
group, 16 out of 141 patients [11.3%; 95% CI0(6.6,
17.8%)] experienced a wound infection and/or a reoperation
due to burst abdomen. No significant difference between
treatment groups was found (p00.31).
Table 2 Recruitment
ISSAAC INSECT
PDS
®+MonoPlus
® PDS
® MonoPlus
®
Heidelberg 80 40 20 20
Munich 51 39 19 20
Lingen 16 36 18 18
Marburg 3 27 14 13
Total 150 142 71 71
Table 3 Patients’ baseline
characteristics
aMeasured in only 127 INSECT
and 146 ISSAAC patients
ISSAAC INSECT p value
N0150 N0141
Age (years), mean±SD
Male 63.1±11.1 63.9±12.3. 0.66
Female 64.9±12.8 60.5±16.2 0.10
Gender
Male 80 (53.3%) 90 (63.8%) 0.075
Female 70 (46.7%) 51 (36.2%)
BMI (kg/m
2), mean±SD 25.3±4.0 25.5±3.7 0.80
Prior abdominal incisions 32 (21.3%) 47 (33.3%) 0.025
Rectus diastasis 3 (2.0%) 5 (3.5%) 0.49
Umbilical hernia 3 (2.0%) 2 (1.4%) 1.00
Smokers 24 (16.0%) 18 (12.7%) 0.50
Surgical procedures
Colon 40 (26.7%) 53 (37.6%) <0.0001
Rectum 12 (8.0%) 25 (17.7%)
Stomach and oesophagus 23 (15.3%) 14 (9.9%)
Abdominal aorta 2 (1.3%) 10 (7.1%)
Pancreas 49 (32.7%) 18 (12.8%)
Small intestine 6 (4.0%) 4 (2.8%)
Other 18 (12.0%) 13 (9.2%)
Length of abdominal wound (cm)
a, mean±SD 24.1±4.6 23.5±5.3 0.39
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For further evaluation of secondary endpoints, both compli-
cations of the combined primary endpoint have been ana-
lysed separately.
Burst abdomen
The rate of burst abdomen until the day of discharge in the
ISSAAC study group (2.0%; Table 4) was equal to the
INSECT control group (2.8%; p01.0).
Wound infections
The wound infection rate until the day of discharge in the
ISSAAC study group (6.7%; Table 4) was comparable to the
INSECT control group (9.2%; p00.52). Twenty-three
(15.3%) patients of the ISSAAC study group developed a
wound infection during the first 30 days after surgery. In the
control group, 18 (12.7%) wound infections were recorded
until 6 months after surgery. For comparison, wound infec-
tions occurring until 1 year postoperatively were also ana-
lysed in the ISSAAC study cohort. One additional wound
infection was seen during this period in the ISSAAC group.
Therefore, most of the wound infections occurred within the
first month and no difference was observed between the two
study groups (Table 4).
The 10 patients with wound infection were by 2.5 (−0.1;
5.2) kg/m
2 more overweight than the patients without
wound infections, while only two wound infection patients
had a BMI above 30 kg/m
2. Five of the 10 wound infection
patients were smokers while 42% of the patients not infected
were smokers (not significant). Eight of the patients with
wound infections underwent colon surgery; one patient was
operated on for rectal carcinoma and one for a tumour in the
lower left abdomen.
Complicated wound healing
Complicated wound healing as defined above were not
documented in the INSECTstudy. Therefore, this parameter
is only recorded for MonoMax® patients. In total, 30 com-
plicated wound healings were reported in 147 patients until
30 days postoperatively.
Length of hospital stay
Patients of both study groups stayed in hospital for a median
duration of 11 days after surgery (Table 4).
Incisional hernia rate
In the ISSAAC cohort, 21 hernias were observed in 150
patients within 1 year after surgery. Thirty hernias were
present in the INSECT control group (Table 4). A Kaplan–
Meier analysis rendered a 1-year hernia risk of 18.6% [95%
CI (11.4%; 25.8%)] in ISSAAC patients and 25.4% [95% CI
(17.6%; 33.3%)] for INSECT patients. A proportional haz-
ard test for difference between the two study cohorts with
respect to the risk of incisional hernia with centre included
as fixed effects rendered a p value of 0.22, the point estimate
of relative risk being at 69%. More hernias in the INSECT
group were recorded as fascial gaps in comparison to the
ISSAAC group [N028 (19.9%) vs. N017 (11.3%)]. The
number of bulging sacs was N016 (10.7%) in the ISSAAC
study vs. N015 (10.6%) for INSECT.
Among the 21 hernias, there were five obese (BMI>
30 kg/m
2) patients, which was not significantly more than
16 among the non-hernia patients, but the mean BMI was
Table 4 Results
aObserved for only 148 ISSAAC
and 139 INSECT patients
ISSAAC INSECT p value
N0150 N0141
Primary endpoint
Burst abdomen and/or wound infection until day of discharge 11 (7.3%) 16 (11.3%) 0.31
Secondary endpoints
Burst abdomen until day of discharge 3 (2.0%) 4 (2.8%) 1.0
Wound infection
Until day of discharge 10 (6.7%) 13 (9.2%) 0.52
Within 30 days 23 (15.3%)
Within 6 months 18 (12.7%)
Within 1 year 24 (16.0%)
Length of hospital stay (days), median (quartile 1, 3)
a 11 (8, 15) 11 (8, 16) 0.81
Incisional hernia within 1 year 21 (14.0%) 30 (21.3%) 0.22
Fascial gap 17 (11.3%) 28 (19.9%) 0.13
Protruding sac 16 (10.7%) 15 (10.6%) 0.86
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2 in hernia patients compared to
patients without hernia. As for smoking status, there was no
difference seen between hernia and non-hernia patients
(43% vs. 42%).
Adverse events
The reported adverse events occurred mainly in the gastro-
intestinal tract or due to general disorder, injury and proce-
dural complications. Forty-six per cent of the documented
adverse events were estimated as mild, 30% as moderate
and 24% as severe within 1 year. In total, 51 of the adverse
events were assessed as severe in 150 patients. Twenty five
patients deceased within 1 year after surgery mainly due to
the malignant underlying disease. Of the other serious ad-
verse events documented, four (one impaired wound heal-
ing, two burst abdomen and one wound infection) were
recorded with a presumed possibility of association with
the suture material.
Discussion
Abdominal wall closure following primary midline laparot-
omy is still complicated by a relevant number of incisional
hernias that ranges between 9% and 20% [1–4] and, there-
fore, remains a clinical challenge in the daily practice of
surgery. A current systematic review analysing surgical
techniques for abdominal wall closure (INLINE) revealed
a significantly lower incisional hernia rate using a continu-
ous (instead of an interrupted ) suture technique (p00.001)
with a slowly absorbable (instead of a rapidly absorbable)
suture material (p00.009) for elective, primary abdominal
wall closure [20]. Furthermore, comparison of absorbable
vs. non-absorbable sutures irrespectively of the suture tech-
nique showed a significantly lower incisional hernia rate for
absorbable sutures compared to non-absorbable ones. These
findings, that for the first time incorporated data from the
INSECT study, were in contrast to some existing meta-
analyses favouring non-absorbable sutures as the ideal su-
ture material for the closure of midline incisions [15, 16].
MonoMax® is a monofilament suture material with high
elasticity and long-lasting tensile strength. It, therefore,
posses the criteria of a good suture material for abdominal
wall closure as discussed in the INLINE meta-analysis [20].
MonoMax® may, additionally, facilitate abdominal wall
closure through its high elasticity, as experimental data
indicate an important role of increased suture tension for
the development of incisional hernias [26].
The primary objective of this clinical study was to dem-
onstrate the safety of MonoMax® suture material. The safe-
ty parameters “rate of burst abdomen” and “wound
infections until the day of discharge” were therefore chosen
as a combined primary endpoint as opposed to incisional
hernia development which was the primary endpoint in the
INSECTstudy. It was expected that the combined frequency
of these parameters should be equal or lower than in the
INSECT control group.
A lower number of ISSAAC patients experienced a burst
abdomen and/or a wound infection compared to INSECT
control patients (7.3% vs. 11.3%), but this difference was
not significant. We therefore conclude that MonoMax®
suture material is as safe as current sutures for abdominal
wall closure.
From our experience, one should, however, avoid a too
forced elongation of the elastic filament, as this—when the
suture retracts to its normal length—may increase the risk of
tissue ischemia on the wound edges. This recommendation
is in line with experimental data on the importance of suture
tension [26].
Wound infections remain the most important early post-
operative complication as within the first 30 days postoper-
atively they develop in 3–21% of patients undergoing a
midline laparotomy [4–9]. In the current study, wound
infections were observed in 6.7% of ISSAAC patients com-
pared to 9.2% in the INSECT control group until the day of
discharge. An increase to 15.3% was seen in ISSAAC
patients after 1 month and to 12.4% in INSECT patients
after 6 months postoperatively. Seiler et al. [1] concluded
that a wound infection rate of 16% (for all study centres)
found in the INSECT study despite the antibiotic prophy-
laxis which was received by nearly all included patients
(98%) was higher than expected. Our results confirm the
high wound infection rate observed in the INSECT and
other studies.
The development of wound infections depends on a
number of factors; suture material is one of them, suture
technique another, and all need to be put at stake. While the
present study focused on a specific innovative suture mate-
rial, a recent study from Millbourn et al. showed that the
wound infection rate after primary midline incision may be
decreased with a monofilament suture material by simply
placing stitches less than 10 mm from the wound edge [27].
Further efforts are required to reduce this burden of
complication.
The frequency of burst abdomen until the day of dis-
charge in the current study was 2.0% for the ISSAAC study
group and 2.8% for the INSECT control group. This lies
within the range of 1–3% reported in the literature [5–8]. In
sum, early postoperative complications following abdomi-
nal wall closure with MonoMax® did not differ significantly
from data for other suture materials.
The absence of incisional hernia is the most important
long-term criterion of successful abdominal wall closure. In
the literature, the incidence of postoperative hernia varies
between 9% and 20% depending on the suture technique
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patients in 25 participating centres, analysed if the continu-
ous suture technique was better than the interrupted suture
technique for abdominal wall closure [1] and found an
overall incisional hernia rate of 11.2% for the continuous
suture technique and 15.9% for the interrupted suture tech-
nique. In contrast, the observed incisional hernia rate was
14.0% in the ISSAAC study group and lower than in the
historical INSECT control group (21.3%) comprising only
the same four ISSAAC study centres (Heidelberg, Munich,
Lingen and Marburg) and only monofilament suture
materials. Therefore, the hernia rate which was seen
withMonoMax® ranked around the mean of published hernia
rates, whereas the hernia rate of the INSECT control group
was found at the upper limit of the reported range.
Concerning the difference in hernia rates between the two
cohorts (11.2% vs. 21.3%) it must, nonetheless, be conced-
ed, that although the four centres had been picked on merit
of their recruitment performance in the INSECT study and
not for their high rate of hernias, some of the difference may
be explained by a regression-to-the-mean effect (i.e. the
phenomenon that if a variable is extreme on its first mea-
surement, it will tend to be closer to the average on a second
measurement). In addition, the study was not powered for
this secondary endpoint. An analysis comparing Mono-
Max® to the entire INSECT population—which would in-
crease the power of the statistical test—was not performed
because centre was too important a factor not to control for
in a historical control approach.
Given the significant number of patients showing a fas-
cial gap and the corresponding risk of hernia development
[28], the originally published study protocol has been
amended to include a 3-year follow-up in order to investi-
gate the long-term incisional hernia rate.
Regarding the adverse events recorded in this study, in 47
of 51 cases a causal connection with the suture material
MonoMax® was excluded. These events were known com-
plications of the patients’ underlying disease or the main
surgical procedure but not abdominal wall closure. In 150
patients, four serious adverse events (2.6% of patients) were
recorded with a possible association with the suture material.
This rate is within the range of what can be expected in this
patient population.
As this was a historically controlled study, changes have
been noticed in the current study in comparison to the
control group which enrolled patients 3 years before the
ISSAAC study. Differences with respect to the population,
the underlying diseases for which the patients were operated
on, as well as to the surgical procedures performed, have
been observed and are most likely caused by the centre
selection. Therefore, and because the present study was
not powered for this parameter, a randomised controlled
trial recruiting a larger patient number is needed in order
to adequately assess the frequency of incisional hernia and
the importance of wound infections for their development
after abdominal wall closure using MonoMax®. Given the
relative similarity of current sutures and the novel character-
istics of MonoMax® suture material, this trial should also
assess parameters like surgeon satisfaction and handling.
In conclusion, the results provided by the ISSAAC study
confirmed that MonoMax® suture material is safe as current
sutures for abdominal wall closure after primary midline
laparotomy. The rate of wound infections in this study was
high but comparable to previous examinations, suggesting
that factors other than the suture material itself might play a
crucial role. A randomised controlled trial including a larger
number of patients will be necessary to evaluate the effi-
ciency of MonoMax® suture material in terms of hernia
development.
Conflicts of interest None.
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